Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jonasson

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosisG Eiriksdottir, G Johannesdottir, S Ingvarsson, et al.
American Journal of Epidemiology|September 4, 2010
A melanoma epidemic in Iceland: possible influence of sunbed useClarisse Héry, Laufey Tryggvadóttir, Thorgeir Sigurdsson, et al.
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
Breast Cancer Research and Treatment|July 17, 2013
Tumour diploidy and survival in breast cancer patients with BRCA2 mutationsLaufey Tryggvadottir, Elinborg J Olafsdottir, Gudridur H Olafsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrenceHeikki Joensuu, Piotr Rutkowski, Toshirou Nishida, et al.
British Journal of Cancer|March 31, 2005
Second primary malignancies in patients with male breast cancerK Hemminki, G Scélo, P Boffetta, et al.
Cancer Cell|November 9, 2010
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancerFerdinandos Skoulidis, Liam D Cassidy, Venkat Pisupati, et al.
Oncogene|August 15, 2019
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancerLaia Piqué, Alexia Martinez de Paz, David Piñeyro, et al.
Endocrine-Related Cancer|April 27, 2017
Obesity and menopause modify the epigenomic profile of breast cancerAna B Crujeiras, Angel Diaz-Lagares, Olafur A Stefansson, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosisG Eiriksdottir, G Johannesdottir, S Ingvarsson, et al.
American Journal of Epidemiology|September 4, 2010
A melanoma epidemic in Iceland: possible influence of sunbed useClarisse Héry, Laufey Tryggvadóttir, Thorgeir Sigurdsson, et al.
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cancer Research|October 10, 1998
High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutationS Ingvarsson, E K Geirsdottir, G Johannesdottir, et al.
Breast Cancer Research and Treatment|July 17, 2013
Tumour diploidy and survival in breast cancer patients with BRCA2 mutationsLaufey Tryggvadottir, Elinborg J Olafsdottir, Gudridur H Olafsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrenceHeikki Joensuu, Piotr Rutkowski, Toshirou Nishida, et al.
British Journal of Cancer|March 31, 2005
Second primary malignancies in patients with male breast cancerK Hemminki, G Scélo, P Boffetta, et al.
Cancer Cell|November 9, 2010
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancerFerdinandos Skoulidis, Liam D Cassidy, Venkat Pisupati, et al.
Oncogene|August 15, 2019
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancerLaia Piqué, Alexia Martinez de Paz, David Piñeyro, et al.
Endocrine-Related Cancer|April 27, 2017
Obesity and menopause modify the epigenomic profile of breast cancerAna B Crujeiras, Angel Diaz-Lagares, Olafur A Stefansson, et al.
Pageof 15